EUVIMEDEUVIMED entdecken
Crossref

Immune and Stromal Barriers to Active Nanoparticle Targeting of Claudin-4 in Tumors

David Angarita, Hanmant Gaikwad, David Siegel, Hanna Mattanovich, Aislinn Warmka, Joshua B. Judson, Kyle A. Sullivan, Elizabeth R. Woodruff, Fabian Villagomez, Tomomi M. Yamamoto, Jesse Hudspeth, Khoi L.M. Nguyen und 8 weitere

ACS Nano · 19.11.2026

DOI: 10.1021/acsnano.6c11570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 19.11.2026. Verfasst von David Angarita und 19 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Gefördert von: University of Colorado, Boettcher Foundation, U.S. Department of War.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles with targeting ligands can act as “magic bullets” to selectively target tumor cells, a concept that has captivated the drug delivery field for decades. Using cell culture, engineered mouse models, and spatial imaging, we studied how cellular interactions influence targeting of claudin-4 (CLDN4), a key ovarian cancer target. We coupled the C-terminal domain of Clostridium perfringens enterotoxin (cCPE), a high-affinity CLDN4 binder, to ∼60 nm dextran iron oxide nanoworms (CLIO NW) via click chemistry. Targeted NWs had nanomolar affinity for CLDN4 and specifically targeted CLDN4+ cells in culture and 3D spheroids. After systemic injection in mice, targeted NWs exhibited a long plasma half-life. In bilateral CLDN4+/CLDN4– xenograft tumors, targeted NWs accumulated more in CLDN4+ tumors but were also taken up by Kupffer cells in the liver and CD45+ immune cells in both tumors. Repeating the study with anti-CLDN4 IgG-decorated NWs, we again observed high in vitro specificity but low in vivo selectivity, as confirmed by optical and magnetic resonance imaging. Spatial proteomic analysis of tumors showed that NWs mainly accumulate in tumor cells, immune cells, and myofibroblasts, with tumor core cells mostly negative for NWs. Cell stress and metabolic profiles remain unchanged after the uptake. Coculture of CLDN4+ tumor cells and macrophages replicated the limited selectivity of targeted NWs in vivo and suggested that complement opsonization contributes to limited selectivity. Overall, stromal and immune uptake hinder CLDN4 targeting. Future efforts should focus on understanding and inhibiting nanoparticle uptake pathways to develop molecularly targeted nanomedicine.

Förderung

  • University of Colorado
  • Boettcher Foundation
  • U.S. Department of War
  • National Institutes of Health

Zitieren

APA

Angarita, D., Gaikwad, H., Siegel, D., Mattanovich, H., Warmka, A., Judson, J. B., Sullivan, K. A., Woodruff, E. R., Villagomez, F., Yamamoto, T. M., Hudspeth, J., Nguyen, K. L., Bitler, B. G., Behbakht, K., Serkova, N. J., Vecchio, A. J., Janetzko, J., Anchordoquy, T. J., Bouchard, G., & Simberg, D. (2026). Immune and Stromal Barriers to Active Nanoparticle Targeting of Claudin-4 in Tumors. ACS Nano. https://doi.org/10.1021/acsnano.6c11570

Vancouver

Angarita D, Gaikwad H, Siegel D, Mattanovich H, Warmka A, Judson JB, et al. Immune and Stromal Barriers to Active Nanoparticle Targeting of Claudin-4 in Tumors. ACS Nano. 2026. doi:10.1021/acsnano.6c11570

BibTeX
@article{Angarita2026,
  author = {Angarita, David and Gaikwad, Hanmant and Siegel, David and Mattanovich, Hanna and Warmka, Aislinn and Judson, Joshua B. and Sullivan, Kyle A. and Woodruff, Elizabeth R. and Villagomez, Fabian and Yamamoto, Tomomi M. and Hudspeth, Jesse and Nguyen, Khoi L.M. and Bitler, Benjamin G. and Behbakht, Kian and Serkova, Natalie J. and Vecchio, Alex J. and Janetzko, John and Anchordoquy, Thomas J. and Bouchard, Gina and Simberg, Dmitri},
  title = {Immune and Stromal Barriers to Active Nanoparticle Targeting of Claudin-4 in Tumors},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c11570}
}
Kostenlos starten →